<--- Back to Details
First PageDocument Content
Medical genetics / Cancer screening / Ribbon symbolism / BRCA mutation / Mutation / Genetic testing / Ovarian cancer / Cancer / In the Family / Medicine / Oncology / Breast cancer
Date: 2013-12-31 10:37:32
Medical genetics
Cancer screening
Ribbon symbolism
BRCA mutation
Mutation
Genetic testing
Ovarian cancer
Cancer
In the Family
Medicine
Oncology
Breast cancer

Screening for Skin Cancer

Add to Reading List

Source URL: www.uspreventiveservicestaskforce.org

Download Document from Source Website

File Size: 55,88 KB

Share Document on Facebook

Similar Documents

Cancer / Breast cancer / Health / Clinical medicine / Tumor suppressor genes / Tumor markers / Hereditary cancers / RTT / BRCA mutation / BRCA1 / BRCA2 / Myriad Genetics

Outlaw Human Gene Patents Because Human Genes Belong to Human Beings NOT Corporations. The US Supreme Court is currently considering the question

DocID: 1qIXp - View Document

RTT / Health / Cancer / Clinical medicine / Ovarian cancer / Breast cancer / Smoking / Cigarette / Ovarian Cancer National Alliance / BRCA mutation

ENGLISH SUMMARY Ovarian cancer is the most lethal gynaecologic cancer. Today, there is no population-based screening tool in ovarian cancer and as the disease typically has a vague clinical presentation; most women are d

DocID: 1quQa - View Document

Breast cancer / RTT / Cancer screening / Ribbon symbolism / Hereditary cancers / Breast cancer screening / Mammography / BRCA mutation / BRCA2 / BRCA1 / Breast imaging / Cancer

CNE Objectives and Evaluation Form appear on pageSERIES Deciphering the Diagnostics of Breast Cancer

DocID: 1oQ5n - View Document

Cancer screening / Breast surgery / Cancer / Ovarian cancer / Mammography / Mammary ductal carcinoma / Metastasis / Mastectomy / BRCA mutation / Medicine / Breast cancer / Ribbon symbolism

S P E C I A L A D V E R T I S I N G eauty

DocID: 19JOV - View Document

Tumor markers / Tumor suppressor genes / BRCA mutation / Breast cancer / Lactams / PARP inhibitor / BRCA2 / Ovarian cancer / BRCA1 / Medicine / Oncology / Mutation

ARIEL2: A phase 2 study to prospectively identify ovarian cancer patients likely to respond to rucaparib Elizabeth Swisher,1 James Brenton,2 Scott Kaufmann,3 Amit Oza,4 Robert L. Coleman,5 David O’Malley,6 Gottfried Ko

DocID: 19bpI - View Document